Amphetamine Cocaine Interaction Study - 2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00000305

Recruitment Status : Terminated (Original P.I. left the institution)

First Posted : September 21, 1999

Last Update Posted : May 18, 2012

Sponsor:

Collaborators:

National Institute on Drug Abuse (NIDA)

University of Texas

Information provided by (Responsible Party):

The University of Texas Health Science Center, Houston

Tracking Information

First Submitted Date ^ICMJE

September 20, 1999

First Posted Date ^ICMJE

September 21, 1999

Last Update Posted Date

May 18, 2012

Study Start Date ^ICMJE

Not Provided

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Mood indicators
Psychiatric interview
Craving
Drug use
Medication compliance
Retention
Addiction severity

Change History

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Pre-specified Outcome Measures

Not Provided

Original Other Pre-specified Outcome Measures

Not Provided

Descriptive Information

Brief Title ^ICMJE

Amphetamine Cocaine Interaction Study - 2

Official Title ^ICMJE

Amphetamine Cocaine Interaction Study

Brief Summary

The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase ^ICMJE

Phase 1

Study Design ^ICMJE

Primary Purpose: Treatment

Condition ^ICMJE

Cocaine-Related Disorders

Intervention ^ICMJE

Drug: Dextroamphetamine

Study Arms ^ICMJE

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Terminated

Enrollment ^ICMJE

Original Enrollment ^ICMJE

Same as current

Study Completion Date ^ICMJE

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Please contact site for information.

Sex/Gender ^ICMJE

Sexes Eligible for Study:

Male

Ages ^ICMJE

18 Years to 45 Years (Adult)

Accepts Healthy Volunteers ^ICMJE

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Listed Location Countries ^ICMJE

United States

Removed Location Countries

Administrative Information

NCT Number ^ICMJE

NCT00000305

Other Study ID Numbers ^ICMJE

NIDA-09262-2
P50DA009262 ( U.S. NIH Grant/Contract )
P50-09262-2

Has Data Monitoring Committee

Yes

U.S. FDA-regulated Product

Not Provided

IPD Sharing Statement ^ICMJE

Not Provided

Responsible Party

The University of Texas Health Science Center, Houston

Study Sponsor ^ICMJE

The University of Texas Health Science Center, Houston

Collaborators ^ICMJE

National Institute on Drug Abuse (NIDA)
University of Texas

Investigators ^ICMJE

Principal Investigator:

John Grabowski, Ph.D.

University of Texas

PRS Account

The University of Texas Health Science Center, Houston

Verification Date

May 2012

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top